These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9031774)

  • 1. False-positive I-131 whole-body imaging after I-131 therapy for a follicular carcinoma.
    Andreas J; Brühl K; Eissner D
    Clin Nucl Med; 1997 Feb; 22(2):123-4. PubMed ID: 9031774
    [No Abstract]   [Full Text] [Related]  

  • 2. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
    Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):114-7. PubMed ID: 16128228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tracheostomy cannula as a cause of false positive result on the whole-body scan with (131)I in the follow-up of differentiated thyroid cancer].
    Vallejo Casas JA; Mena Bares ML; Gálvez Moreno MA; Latre Romero JM
    Rev Esp Med Nucl; 2011; 30(6):384-5. PubMed ID: 21546127
    [No Abstract]   [Full Text] [Related]  

  • 4. Occult carcinoma of the thyroid presenting with orbital metastasis.
    Mansberg R; Son H; Kean AM
    Clin Nucl Med; 2006 Feb; 31(2):109-11. PubMed ID: 16424702
    [No Abstract]   [Full Text] [Related]  

  • 5. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal scarring causing false-positive uptake on I-131 whole-body imaging.
    Schuster DM; Alazraki N
    Clin Nucl Med; 1998 May; 23(5):334. PubMed ID: 9596168
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we read carefully?
    Medvedec M
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):475-6. PubMed ID: 12634977
    [No Abstract]   [Full Text] [Related]  

  • 10. Follow-up of differentiated thyroid cancer.
    Pacini F
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S492-6. PubMed ID: 12192551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid carcinoma: iodine-131-negative whole-body scan reverses to positive after a combination of thyrogen stimulation and withdrawal.
    Kasner DL; Spieth ME; Starkman ME; Zdor-North D
    Clin Nucl Med; 2002 Nov; 27(11):772-80. PubMed ID: 12394123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
    Kalinyak JE; McDougall IR
    Nucl Med Commun; 2004 Sep; 25(9):883-9. PubMed ID: 15319592
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
    Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
    Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I-131 accumulation in folliculitis of the scalp.
    Kinuya S; Yokoyama K; Michigishi T; Tonami N
    Clin Nucl Med; 1996 Oct; 21(10):807-8. PubMed ID: 8896935
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioiodine pooling in dilated greater saphenous vein mimicking contamination.
    Varoglu E; Yildirim M; Bayrakdar R; Kantarci AM; Uslu H
    Clin Nucl Med; 2003 Oct; 28(10):866-8. PubMed ID: 14508289
    [No Abstract]   [Full Text] [Related]  

  • 16. An interesting contamination artifact appearing in I-(131) whole-body imaging after ablative therapy.
    Ozcan Kara P; Sari O; Gedik GK; Kocak I; Kaya B
    Rev Esp Med Nucl; 2011; 30(1):36-7. PubMed ID: 21211869
    [No Abstract]   [Full Text] [Related]  

  • 17. False-positive "necklace sign" on whole-body thyroid cancer survey--a case report.
    Beaulieu S; Djang D; Minoshima S
    J Nucl Med Technol; 2005 Mar; 33(1):42-3. PubMed ID: 15731020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.
    Patel SS; Goldfarb M
    J Surg Oncol; 2013 May; 107(6):665-72. PubMed ID: 23192391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma.
    Silberstein EB
    J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer.
    Fatourechi V; Hay ID; Javedan H; Wiseman GA; Mullan BP; Gorman CA
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1521-6. PubMed ID: 11932275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.